Open AccessPhase II Studies in Soft Tissue Sarcoma: Time for Reappraisal
Author(s) -
Sleijfer Stefan
Publication year - 2012
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2011-0382
Subject(s) - medicine , sorafenib , angiosarcoma , soft tissue sarcoma , sarcoma , oncology , phases of clinical research , clinical trial , surgery , pathology , hepatocellular carcinoma
A phase II study with sorafenib in patients with angiosarcoma conducted by the French Sarcoma Group, and published in this issue of The Oncologist , is evaluated. The importance of proper design and conduct of phase II trials is stressed.